DJSG
LGND icon

D.J. St. Germain’s Ligand Pharmaceuticals LGND Stock Holding History

D.J. St. Germain’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Hold
75
– – ﹤0.01% 608
2025
Q4 		$14.2K Hold
75
– – ﹤0.01% 622
2025
Q3 		$13.3K Hold
75
– – ﹤0.01% 617
2025
Q2 		$8.53K Hold
75
– – ﹤0.01% 672
2025
Q1 		$7.89K Hold
75
– – ﹤0.01% 592
2024
Q4 		$8.04K Hold
75
– – ﹤0.01% 612
2024
Q3 		$7.51K Hold
75
– – ﹤0.01% 575
2024
Q2 		$6.32K Hold
75
– – ﹤0.01% 592
2024
Q1 		$5.48K Hold
75
– – ﹤0.01% 600
2023
Q4 		$5.36K Hold
75
– – ﹤0.01% 612
2023
Q3 		$4.49K Hold
75
– – ﹤0.01% 593
2023
Q2 		$5.41K Buy
+75
New +$5.63K ﹤0.01% 580

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

D.J. St. Germain's LGND Position: Q1 2026 in Review

D.J. St. Germain held its Ligand Pharmaceuticals (LGND) position steady in Q1 2026 at 75 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

D.J. St. Germain first reported a position in LGND in Q2 2023 and has held it in 12 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • D.J. St. Germain held 75 shares of Ligand Pharmaceuticals worth $15K as of Q1 2026.
  • D.J. St. Germain left its Ligand Pharmaceuticals share count unchanged in Q1 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of D.J. St. Germain's portfolio in Q1 2026, its #608 holding.
  • D.J. St. Germain first reported a position in Ligand Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.